Fingerprint
Dive into the research topics of 'The BOLERO-2 trial: The addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically